INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

18,927 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$57K
9,075 sh
Jan 9, 2026Jan 12, 2026
Page 377 of 474
← PrevNext →

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELL
traded Jan 9, 2026
+3d
SEC Form 4

Evidence

17
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$180K
32.7K sh
Jan 12, 2026Jan 12, 2026
traded Jan 12, 2026
+0dSEC Form 4

Evidence

17
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$575K
17.8K sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

17
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$829K
50.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.34M
632.9K sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

16
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$219K
856 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

16
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
780 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.99M
632.9K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

16
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$174K
700 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

15
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
41.2K sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$19K
3,195 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$192K
2,514 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

13
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
100 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

12
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$842K
33.8K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

11
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$407K
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

11
MJ
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER
OMCLOMNICELL, INC.
Open-market sale · 10b5-1 plan
SELL$305K
6,106 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

9
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$151K
7,500 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

8
TD
Tesh Thomas DChief Admin. Officer
ROLROLLINS INC
Open-market sale · 10b5-1 plan
SELL$144K
2,396 sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

8
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$241K
10.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$747K
45.0K sh
Jan 12, 2026Jan 12, 2026
traded Jan 12, 2026
+0dSEC Form 4

Evidence

45
GS
Gillai SaarDirector
SMTCSEMTECH CORP
Open-market sale
SELL$271K
3,600 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

44
MB
Mcrae Matthew BlakeDirector, CEO
ARLOArlo Technologies, Inc.
Open-market sale
SELL$1.23M
90.1K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

41
ZL
Zitkus LesterSVP, Land
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$300K
1,606 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

41
ZL
Zitkus LesterSVP, Land
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$450K
2,439 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

41
BJ
Binder Kurtis JosephCHIEF FINANCIAL OFFICER
ARLOArlo Technologies, Inc.
Open-market sale
SELL$754K
55.0K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

38
ZL
Zitkus LesterSVP, Land
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$131K
700 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

35
KA
Kashani AliDirector, Chief Executive Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$130K
9,088 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

35
PT
Parang TourajDirector, President & COO
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$57K
4,008 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

34
KK
Krumm KevinChief Financial Officer
FLEXFLEX LTD.
Open-market sale
SELL$1.30M
21.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

33
BB
Busse BrianGENERAL COUNSEL
ARLOArlo Technologies, Inc.
Open-market sale
SELL$258K
18.8K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

32
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$639K
14.3K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

32
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.01M
25.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

32
AE
Abraham EuanChief Hardware & Mftg Offcr
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$17K
1,171 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

31
SA
Sutherland Vanessa AllenEVP, GC and Secretary
PSXPhillips 66
Open-market sale
SELL$637K
4,394 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

30
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$5.64M
21.7K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

30
SA
Schacterle AmyChief Regulatory Officer
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$2,176
1,097 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

29
LF
Lizzul Paul F.Chief Medical Officer
ANABANAPTYSBIO, INC
Open-market sale
SELL$163K
3,650 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

29
CJ
Connelly JackPortfolio Manager
IQIInvesco Quality Municipal Income Trust
Open-market sale
SELL$39K
3,900 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

29
DN
Doherty John N.EVP, CFO
BFLYButterfly Network, Inc.
Open-market sale
SELL$240K
60.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

26
DJ
Doherty James J.President and CDO
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$12K
6,467 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

SYMSymbotic Inc.Oct 26 – Nov 2
7 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K